Sivik Global Healthcare’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
Sivik Global Healthcare's BLUE Position: Q3 2020 in Review
Sivik Global Healthcare sold out of bluebird bio (BLUE) in Q3 2020, closing a stake of 2,702 shares — an estimated $2.14M sold.
Sivik Global Healthcare first reported a position in BLUE in Q1 2015 and held it in 18 quarters. The position peaked at $3.92M in Q2 2018. 275 funds tracked by Wall St. Rank hold BLUE as of Q3 2020.
- Sivik Global Healthcare reported no remaining bluebird bio position as of Q3 2020 after selling out during the quarter.
- Sivik Global Healthcare sold 2,702 bluebird bio shares in Q3 2020, an estimated $2.14M.
- Sivik Global Healthcare first reported a position in bluebird bio in Q1 2015 and held it in 18 quarters.
- Sivik Global Healthcare's bluebird bio position peaked at $3.92M in Q2 2018.
- 275 funds tracked by Wall St. Rank held bluebird bio as of Q3 2020.
Based on Sivik Global Healthcare's 13F filing for Q3 2020, filed 13 Nov 2020.